#ozempic
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR
OneSource notches a second generic semaglutide approval in Canada, through partner
The generic version of Ozempic from Canadian-based Apotex, has been approved, Health Canada said, adding that it was the second generic approved, even as seven applications were being reviewed